Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe website’s footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check8 days agoChange DetectedThe record history adds version 17, submitted 2026-09-29, listing updates to study status, outcome measures, participant flow, baseline characteristics, adverse events, and document sections. It also shows that quality-control review has not concluded and the record was returned on 2026-10-20.SummaryDifference2%

- Check15 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check22 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check29 days agoChange DetectedThe study record now indicates that results have been submitted, replacing the previous notice that no results were posted.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study record history shows a new revision entry labeled v3.7.0, replacing the previous revision v3.6.6. This update reflects a metadata change to the record's revision history rather than to the study data itself.SummaryDifference0.1%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.